Combination of weekly streptozocin and oral S-1 treatment for patients of unresectable or metastatic pancreatic neuroendocrine neoplasms.
Hiroaki OnoAtsushi KudoKeiichi AkahoshiToshiro OguraKosuke OgawaDaisuke BanShinji TanakaMinoru TanabePublished in: Journal of cancer research and clinical oncology (2019)
STS1 treatment is an effective and safe therapeutic option for patients with advanced Pan-NEN.